Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_assertion type Assertion NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_head.
- NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_provenance.
- NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_assertion evidence source_evidence_literature NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_provenance.
- NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_assertion SIO_000772 1333884 NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_provenance.
- NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_assertion wasDerivedFrom befree-20140225 NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_provenance.
- NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_assertion wasGeneratedBy ECO_0000203 NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_provenance.